Filing Details
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) filed a Form 8-K with the Securities and Exchange Commission on August 04, 2026, disclosing a material event.
8k filedNASDAQ:RANI
Rani Therapeutics Holdings, Inc. (RANI) Reports Material Event to SEC
Filing Details Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) filed a Form 8-K with the Securities and Exchange Commission on August 04, 2026, disclosing a material event. Market…
Market Context
Rani Therapeutics Holdings, Inc.'s stock currently trades at $0.82 with a market capitalization of $107.3M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Rani Therapeutics Holdings, Inc.'s stock.
All SEC filings for Rani Therapeutics Holdings, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View RANI Stock Page
Frequently Asked Questions
Where can I read RANI's SEC filings?
Browse all filings on our RANI SEC filings page.
What types of SEC filings does Rani Therapeutics Holdings, Inc. file?
Public companies like Rani Therapeutics Holdings, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.